Pemphigus vulgaris (PV) is a rare, potentially life-threatening autoimmune blistering disease affecting the skin and surface-close mucous membranes. It is characterized by autoantibodies against two desmosomal antigens, desmoglein (Dsg) 1 and 3. These anti-Dsg autoantibodies are detected in nearly all PV patients and are pathogenic, as demonstrated in both in vitro and in vivo studies.

Although familial cases of pemphigus are extremely rare, they are well-documented. Approximately half of the first-degree relatives of PV patients exhibit circulating autoantibodies without clinical lesions. Genetic risk factors, particularly at the HLA locus and to a lesser extent at non-HLA loci, are associated with PV. Notably, the presence of pemphigus-specific autoantibodies in relatives often correlates with the same HLA alleles found in PV patients. 

This study aims to identify novel susceptibility loci associated with an increased risk of developing autoantibodies and clinical disease. To achieve this, whole genome sequencing (WGS) and in vitro functional analyses of anti-Dsg3 IgG will be conducted in PV patients and their first-degree relatives. 

By identifying new genetic factors related to the predisposition, onset, and progression of PV, this project may enable early identification of at-risk individuals. Such knowledge could facilitate the development of targeted therapies and personalized medicine strategies for managing pemphigus.